查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2028 年脓毒症诊断市场预测——COVID-19 的影响和按产品、技术、方法、测试类型、病原体和最终用户进行的全球分析
市场调查报告书
商品编码
1187265

2028 年脓毒症诊断市场预测——COVID-19 的影响和按产品、技术、方法、测试类型、病原体和最终用户进行的全球分析

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User
出版日期: | 出版商: The Insight Partners | 英文 267 Pages | 商品交期: 1-5个工作天内

价格

全球败血症诊断市场预计将从 2021 年的 6.6183 亿美元增长到 2028 年的 12.2652 亿美元，从 2021 年到 2028 年的复合年增长率为 9.2%。我来了。 由于院内感染增加导致脓毒症发病率上升以及对快速诊断测试的需求不断增长导致产品发布增加等因素正在推动脓毒症诊断市场的整体增长。 然而，缺乏熟练的专业人员正在阻碍败血症诊断市场的增长。

败血症是人体对感染的极端反应。 脓毒症是一种严重的临床病症，可能由其他感染引起，包括 COVID-19 和流感等病毒感染。 这是危及生命的医疗紧急情况。 早期发现和特定的临床干预对于改善脓毒症患者的预后至关重要。 细菌性败血症涉及一系列反应，包括细胞缺氧、参与消除细菌及其颗粒的免疫复合物失活，以及进展为多器官衰竭。 许多医生认为脓毒症是一种三阶段综合症，从脓毒症开始，然后是严重的脓毒症，然后是感染性休克，被认为是医疗急症。 败血症的特征是高死亡率和发病率。 败血症诊断学是诊断败血症的研究，败血症是一种严重的临床病症，通常由原发性细菌感染或不太常见的真菌和/或病毒感染引起。 根据国家生物技术信息中心2019年2月发表的一篇论文，败血症的死亡率为25%至30%。

许多针对败血症的诊断测试非常耗时，最多可能需要 72 小时才能出结果。 在所有疾病的分子诊断时代，对败血症快速诊断检测的需求越来越大。 因此，该行业的许多主要参与者都专注于开发创新的败血症快速诊断测试。 例如，2020 年 9 月，总部位于巴塞罗那的 Loop Diagnostics 推出了即时诊断平台。 该平台取代了传统的血培养分析方法，可快速提供结果。 基于血液的标记物还可以识别细菌感染，并在两小时内提供检测结果，准确率为 99%。 此外，2020年5月，Beckman在美国推出了具有早期败血症指标的新型血液学分析仪DxH 690T。

此外，领先的公司已经开发出具有成本效益的诊断测试，以克服与诊断败血症相关的所有挑战。 例如，分子诊断先驱 Inflammatix 发布了一个健康经济学模型，表明与标准方法相比，使用其 HostDxTM Sepsis 测试具有成本效益。 该测试是在疑似急性呼吸道感染 (ARTI) 的急诊科患者中进行的。 这项研究于 2020 年 4 月发表在《卫生经济学与成果研究杂誌》上。 该模型让医院临床医生了解广泛采用 HostDx Sepsis 测试的潜在临床和经济效益。

此外，近年来对败血症快速诊断的需求不断增长，刺激了各大公司的研究活动。 脓毒症诊断领域的现有企业和初创企业都得到了政府和研究机构的大力支持。 例如，2020 年 4 月，Cytovale Inc. 与生物医学高级研究与发展局 (BARDA) 合作，对包括 COVID-19 在内的呼吸道感染患者进行败血症诊断。 该研究估计耗资 590 万美元，其中 BARDA 出资约 383 万美元。 因此，在预测期内，有效疗法的推出和正在进行的临床试验将为脓毒症诊断市场提供有利可图的机会。

全球败血症诊断市场根据产品、技术、方法、测试类型、病原体和最终用户进行细分。 基于产品，脓毒症诊断市场分为仪器、试剂和化验、血液培养基和软件。 据估计，血培养液部分将在 2021-2028 年占据最大的市场份额。 根据《临床微生物学家学会杂誌》的报导，血培养有助于确定脓毒症的病原体，适当选择经验性和特异性抗生素，并指导进一步调查以确定感染病灶。它仍然是最重要的方法之一脓毒症管理的重要调查，因为它能够 建议对所有脓毒症患者进行血培养。 血液培养系统的自动化使得能够在尽可能短的时间内收集到最大数量的病原体，从而改善患者管理并挽救生命。 强烈推荐这种方法，因为它在脓毒症患者的诊断检查中揭示了最高水平的证据。 上述因素支持血培养液部分的市场增长，并最终推动败血症诊断市场的增长。

预计在预测期内，软件部分将在败血症诊断市场实现最高的复合年增长率。 一些参与全球败血症诊断市场的顶级公司不断推出各种软件，以保持在市场的前沿。 例如，Mobile Technologies 发布了 Nerve center Software，它在败血症和其他危及患者生命的疾病的早期检测中发挥着关键作用。 新软件使用生命体征和病理结果自动进行脓毒症的早期诊断，如果发现脓毒症风险，可以立即通过移动设备向适当的医生和护士发出警报。

在编写全球败血症诊断市场报告时，参考了主要和次要来源，包括世界卫生组织 (WHO)、疾病控制和预防中心 (CDC)、国家医学图书馆和国家生物技术中心信息 (NCBI)。

内容

第一章介绍

  • 调查范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 全球脓毒症诊断市场 - 按产品分类
    • 全球脓毒症诊断市场 - 按技术分类
    • 全球脓毒症诊断市场 - 按方法
    • 全球脓毒症诊断市场——按测试类型
    • 脓毒症诊断的全球市场（按病原体分类）
    • 全球脓毒症诊断市场——按最终用户分类
    • 全球脓毒症诊断市场 - 按地区

第二章重点

第三章研究方法论

  • 范围
  • 二次调查
  • 初步调查

第4章脓毒症诊断试剂市场-市场概况

  • 害虫分析
    • 北美 PEST 分析
    • 欧洲 PEST 分析
    • 亚太地区 PEST 分析
    • 中东和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 专家意见

第 5 章脓毒症诊断市场 - 主要市场动态

  • 市场驱动力
    • 因院内感染增加而导致败血症的高发病率
    • 对快速诊断测试的需求不断增加，产品发布也越来越多
  • 市场製约因素
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加对败血症诊断研究的资助和支持
  • 未来趋势
    • 脓毒症诊断技术不断进步
  • 影响分析

第 6 章脓毒症诊断市场 - 全球分析

  • 脓毒症诊断全球市场收入预测和分析
    • 全球败血症诊断市场收入预测和分析
    • 主要参与者的市场定位
    • 全球败血症诊断市场 - 市场潜力分析，按地区
  • 比较公司分析
    • 增长战略分析
    • 主要参与者的表现
      • 生物梅里埃
      • 丹纳赫
    • 败血症诊断市场份额分析

第 7 章：脓毒症诊断全球市场收入和到 2028 年的预测 – 按产品分类

  • 全球败血症诊断市场，按产品划分，2021 年和 2028 年 (%)
  • 设备
  • 试剂和化验
  • 血液培养基
  • 软件

第 8 章脓毒症诊断市场收益和到 2028 年的预测（技术版）

  • 按技术划分的脓毒症诊断试剂全球市场份额 - 2021 年和 2028 年 (%)
  • 分子生物学诊断方法
      • 聚合□链反应
      • 多□核酸-荧光原位杂交
      • 基于综合症小组的检查
      • 微阵列
  • 流式细胞仪
    • 实时细胞分析
      • 基于 TaqMan 的多重 RT PCR 和血培养
      • Magicplex(TM) 败血症实时测试 - 在意大利都灵 Regina Margherita 儿童医院进行的案例研究
      • 败血症诊断解决方案提供商
      • 通过实时 PCR 诊断脓毒症
      • 新一代测序的新方法以及技术进步和创新
      • 通过阻抗测量进行实时细胞分析
  • 微流体
  • 免疫测定
  • 生物标誌物
    • 代谢组学
      • 脓毒症的代谢组概况
      • 代谢组学在败血症诊断中的传播和应用
      • 通过代谢组分析早期预测败血症
      • 组学在脓毒症诊断和治疗中的未来作用
      • 败血症生物标誌物和诊断工具
      • 代谢组学和蛋白□□质组学在败血症中的作用
      • 寻找预测急性肾功能衰竭预后的小分子生物标誌物的可能性
      • 代谢组学在败血症诊断中的最新应用
      • 线粒体功能中的代谢组学
      • 代谢组学在线粒体医学诊断中的巨大潜力
  • 微生物学

第 9 章脓毒症诊断市场收入和到 2028 年的预测 - 方法论

  • 按方法划分的脓毒症诊断试剂全球市场份额 - 2021 年和 2028 年 (%)
  • 自动诊断
  • 常规诊断方法

第 10 章脓毒症诊断市场收入和到 2028 年的预测（按测试类型）

  • 全球败血症诊断试剂市场：按测试类型划分的份额 - 2021 年和 2028 年 (%)
  • 即时检测
  • 实验室测试

第 11 章败血症诊断市场收益和到 2028 年的预测 - 病原体

  • 2021 年和 2028 年按病原体划分的脓毒症诊断全球市场份额 (%)
  • 细菌性败血症
  • 霉菌性败血症
  • 其他

第 12 章脓毒症诊断市场收益和到 2028 年的预测（最终用户版）

  • 败血症诊断试剂全球最终用户市场份额 - 2021 年和 2028 年 (%)
  • 医院
  • 病理学和参考实验室
  • 其他

第 13 章全球败血症诊断市场收入和到 2028 年的预测 - 区域分析

  • 北美
    • 生物标誌物
    • 流式细胞仪
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 阿联酋
    • 沙特阿拉伯
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
      • 巴西
Product Code: TIPHE100001391

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing product launches drive the overall growth of the sepsis diagnostics market. However, the lack of skilled professionals hampers the sepsis diagnostics market growth.

Sepsis is the body's extreme response to an infection. Sepsis is a serious clinical condition that can be a result of other infections, including viral infections, such as COVID-19 or influenza. It is a life-threatening medical emergency. Early detection and specific clinical intervention are crucial for improving the outcome of patients suffering from sepsis. Sepsis caused by bacteria involves cascade of reactions, such as lack of oxygen supply to cells and inactivation of immune complexes involved in the clearance of bacteria and its particles, which progresses to multiple organ failure. Sepsis is considered as a three staged syndrome by many physicians that starts with sepsis, leading to severe sepsis, and results in septic shock, which is considered as a medical emergency. Sepsis has a high mortality and morbidity rate. Sepsis diagnostics is the study of diagnosis of sepsis, which is a serious clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. According to an article published by the National Center for Biotechnology Information in February 2019, the mortality rate of sepsis is 25 % to 30 %.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. As a result, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform replaces the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. Additionally, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the US.

Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, published a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Furthermore, the rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Thus, the launch of effective treatments and ongoing clinical trials would provide lucrative opportunities for the sepsis diagnostics market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment is estimated to account for the largest market share during 2021-2028. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points toward further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such aforementioned factors support the market growth for the blood culture media segment and ultimately fuel the growth of sepsis diagnostics market.

The software segment is expected to register the highest CAGR for the overall sepsis diagnostics market during the forecast period. Several top players involved in the global sepsis diagnostics market continuously launch different software to stay forefront in the market. For instance, Mobile Technology announced the launch of Nerve center Software that play an important role in early detection of sepsis and other life-threatening conditions among patients. The new software uses vital signs and pathology results for automating the early diagnosis of sepsis and then ensures that the appropriate doctors and nurses are immediately alerted on their mobile devices when a risk of sepsis has been identified.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Library of Medicine, and National Center for Biotechnology Information (NCBI) are among the primary and secondary sources referred to while preparing the report on the global sepsis diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Sepsis Diagnostics Market - By Product
    • 1.3.2 Global Sepsis Diagnostics Market - By Technology
    • 1.3.3 Global Sepsis Diagnostics Market - By Method
    • 1.3.4 Global Sepsis Diagnostics Market - By Test Type
    • 1.3.5 Global Sepsis Diagnostics Market - By Pathogen
    • 1.3.6 Global Sepsis Diagnostics Market - By End User
    • 1.3.7 Global Sepsis Diagnostics Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Sepsis Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Sepsis Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
    • 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
  • 5.4 Future Trends
    • 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
  • 5.5 Impact Analysis

6. Sepsis Diagnostics Market- Global Analysis

  • 6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
    • 6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
    • 6.1.2 Market Positioning of Key Players
    • 6.1.3 Global Sepsis Diagnostics market - Market Potential Analysis, By Region
  • 6.2 Comparative Company Analysis
    • 6.2.1 Growth Strategy Analysis
    • 6.2.2 Performance of Key Players
      • 6.2.2.1 BioMerieux, Inc.
      • 6.2.2.2 Danaher
    • 6.2.3 Market Share Analysis of Sepsis Diagnostics Market

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

  • 7.1 Overview
  • 7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.4 Reagents and Assays
    • 7.4.1 Overview
    • 7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.5 Blood Culture Media
    • 7.5.1 Overview
    • 7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.6 Software
    • 7.6.1 Overview
    • 7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

  • 8.1 Overview
  • 8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • 8.3 Molecular Diagnostics
    • 8.3.1 Overview
    • 8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Polymerase Chain Reaction
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Syndromic Panel-Based Testing
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.4 Microarrays
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Flow Cytometry
    • 8.4.1 Overview
    • 8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Real-Time Cell Analysis
      • 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
        • 8.4.3.1.1 Characteristics of TaqMan Assays
      • 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
        • 8.4.3.2.1 Abstract
        • 8.4.3.2.2 Conclusion:
      • 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
      • 8.4.3.4 Sepsis diagnosis by real-time PCR
      • 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
      • 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
    • 8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Microfluidics
    • 8.5.1 Overview
    • 8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Immunoassay
    • 8.6.1 Overview
    • 8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Biomarkers
    • 8.7.1 Overview
    • 8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.7.3 Metabolomics
      • 8.7.3.1 Metabolite Profile in Sepsis
      • 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
      • 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
      • 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
        • 8.7.3.4.1 Genomics
        • 8.7.3.4.2 Proteomics
      • 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
      • 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
      • 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
      • 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
      • 8.7.3.9 Metabolics in Mitochondrial Function
      • 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
    • 8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Microbiology
    • 8.8.1 Overview
    • 8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

  • 9.1 Overview
  • 9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • 9.3 Automated Diagnostics
    • 9.3.1 Overview
    • 9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Conventional Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

  • 10.1 Overview
  • 10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • 10.3 Point-of-Care Tests
    • 10.3.1 Overview
    • 10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Laboratory Tests
    • 10.4.1 Overview
    • 10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

  • 11.1 Overview
  • 11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • 11.3 Bacterial Sepsis
    • 11.3.1 Overview
    • 11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Fungal Sepsis
    • 11.4.1 Overview
    • 11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

  • 12.1 Overview
  • 12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • 12.3 Hospitals
    • 12.3.1 Overview
    • 12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.4 Pathology and Reference Laboratories
    • 12.4.1 Overview
    • 12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.5 Others
    • 12.5.1 Overview
    • 12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 13.1 North America: Sepsis Diagnostics Market
    • 13.1.1 Overview
    • 13.1.2 North America: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
    • 13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.1.9.1 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.1 Overview
        • 13.1.9.1.2 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 13.1.9.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.1 Overview
        • 13.1.9.2.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 13.1.9.3 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.1 Overview
        • 13.1.9.3.2 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • 13.2 Europe: Sepsis Diagnostics Market
    • 13.2.1 Overview
    • 13.2.2 Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.3 Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.4 Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 13.2.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    • 13.2.5 Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.6 Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.8 Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.2.9.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.1 Overview
        • 13.2.9.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.1 Overview
        • 13.2.9.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.1 Overview
        • 13.2.9.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.1 Overview
        • 13.2.9.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.1 Overview
        • 13.2.9.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.1 Overview
        • 13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 13.3 Asia Pacific: Sepsis Diagnostics Market
    • 13.3.1 Overview
    • 13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    • 13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
      • 13.3.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    • 13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
    • 13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
    • 13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
    • 13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
    • 13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.3.9.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
        • 13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
        • 13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
        • 13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
        • 13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.2 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.1 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.3 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.1 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.4 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.1 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.5 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.1 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  • 13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028
    • 13.4.1 Overview
    • 13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.4.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.1.1 Overview
        • 13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.2.1 Overview
        • 13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.3.1 Overview
        • 13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.4.1 Overview
        • 13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • 13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
    • 13.5.1 Overview
    • 13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.5.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.5.9.1.1 Overview
        • 13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
    • 13.5.9

List Of Tables

  • Table 1. New next-generation sequencing techniques by Company
  • Table 2. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 3. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 4. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 5. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 6. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 7. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 8. North America Sepsis Diagnostics Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 10. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 11. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 12. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 13. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 14. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 15. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 16. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 17. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 18. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 19. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 20. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 21. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 22. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 23. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 24. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 25. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 26. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 27. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 28. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 29. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 30. Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Europe: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Germany: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Germany: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. UK: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Italy: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Spain: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 80. Asia Pacific: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
  • Table 81. Asia Pacific: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
  • Table 82. Asia Pacific: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
  • Table 83. Asia Pacific: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
  • Table 84. Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 85. China: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 86. China: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
  • Table 87. China: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and forecast to 2028 (USD Million)
  • Table 88. China: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
  • Table 89. China: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
  • Table 90. China: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
  • Table 91. China: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 92. Japan: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 93. Japan: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 94. Japan: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 95. Japan: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 96. Japan: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Japan: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Japan: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 99. India: Sepsis Diagnostics Market, By Product- Revenue and Forecast to 2028(USD Million)
  • Table 100. India: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 101. India: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 102. India: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 103. India: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 104. India: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 105. India: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 106. Australia: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 107. Australia: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 108. Australia: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 109. Australia: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 110. Australia: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 111. Australia: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 112. Australia: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 113. South Korea: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 114. South Korea: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 115. South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 116. South Korea: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 117. South Korea: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 118. South Korea: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 119. South Korea: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 120. Rest of Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 121. Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 122. Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 123. Rest of Asia Pacific: Sepsis Diagnostics Market, By Method- Revenue and Forecast to 2028 (USD Million)
  • Table 124. Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type- Revenue and Forecast to 2028 (USD Million)
  • Table 125. Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen- Revenue and Forecast to 2028 (USD Million)
  • Table 126. Rest of Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 127. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
  • Table 128. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 129. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 130. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 131. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 132. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 133. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 134. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 135. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 136. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 137. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 138. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 139. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 140. UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 141. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 142. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 143. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 144. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 145. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 146. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 147. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 148. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 149. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 150. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 151. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 152. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 153. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 154. South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 155. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 156. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 157. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 158. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 159. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 160. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 161. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 162. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 163. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 164. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 165. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 166. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 167. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 168. South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 169. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 170. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 171. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 172. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 173. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 174. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 175. Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 176. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 177. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 178. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 179. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 180. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 181. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 182. Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 183. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 184. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 185. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 186. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 187. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 188. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 189. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 190. Recent Organic Growth Strategies in Sepsis Diagnostics Market
  • Table 191. Inorganic Developments in the Sepsis Diagnostics Market
  • Table 192. Glossary of Terms

List Of Figures

  • Figure 1. Sepsis Diagnostics Market Segmentation
  • Figure 2. Sepsis Diagnostics Market, By Region
  • Figure 3. Global Sepsis Diagnostics Market Overview
  • Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Sepsis Diagnostics Market, by Geography (US$ Million)
  • Figure 7. Global Sepsis Diagnostics Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Sepsis Diagnostics Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 16. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2021 - 2028
  • Figure 18. Market Positioning of Key Players in Global Sepsis Diagnostics Market
  • Figure 19. Global Sepsis Diagnostics market - Market Potential Analysis, By Region
  • Figure 20. Global Sepsis Diagnostics market - Comparative Company Analysis
  • Figure 21. Global Sepsis Diagnostics Market - Growth Strategy Analysis
  • Figure 22. Market Share Analysis of Key Players in Global Sepsis Diagnostics Market
  • Figure 23. Global Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
  • Figure 24. Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 27. Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • Figure 29. Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 30. Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32. Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 35. Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36. Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 37. Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 38. Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 39. Metabolomics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 40. Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 41. Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • Figure 42. Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 43. Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 44. Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • Figure 45. Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 46. Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 47. Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • Figure 48. Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 49. Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 50. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 51. Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • Figure 52. Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 53. Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 54. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 55. North America: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 56. North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 58. US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Europe: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 62. Europe: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 64. Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Asia Pacific: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 71. Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (USD Million)
  • Figure 72. Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 73. China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 76. Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 77. South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 78. Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 79. Middle East & Africa: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 80. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 81. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 82. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 83. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 84. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 85. Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 86. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
  • Figure 87. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 88. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 89. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 90. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 91. Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
  • Figure 92. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 93. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 96. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
  • Figure 97. Growth Strategies in the Sepsis Diagnostics Market (%)